Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Inami

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biological Psychiatry|September 1, 1985
Somnambulistic behavior associated with abnormal REM sleep in an elderly womanJ Ishigooka, F Westendorp, T Oguchi, et al.
Leukemia|February 16, 2007
Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemiaM Inami, K Inokuchi, M Okabe, et al.
Japanese Journal of Pharmacology|June 1, 1997
Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogsM Inami, I Kawamura, Y Naoe, et al.
Folia Psychiatrica Et Neurologica Japonica|January 1, 1981
Psychomotor status induced by temporal lobe encephalitisM Murasaki, M Inami, K Okamoto, et al.
Anticancer Research|May 5, 1999
Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitorI Kawamura, N Yamamoto, F Sakai, et al.
Anticancer Research|January 11, 2000
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKII Kawamura, E Lacey, M Inami, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1999
Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in miceF Nishigaki, S Tsujimoto, M Inami, et al.
Anticancer Research|November 4, 2000
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activityS Tsujimoto, I Kawamura, M Inami, et al.
Japanese Journal of Cancer Research : Gann|August 14, 1998
Cytotoxic mechanisms of FK317, a new class of bioreductive agent with potent antitumor activityY Naoe, M Inami, I Kawamura, et al.
Japanese Journal of Cancer Research : Gann|March 19, 1999
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in miceY Naoe, I Kawamura, M Inami, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biological Psychiatry|September 1, 1985
Somnambulistic behavior associated with abnormal REM sleep in an elderly womanJ Ishigooka, F Westendorp, T Oguchi, et al.
Leukemia|February 16, 2007
Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemiaM Inami, K Inokuchi, M Okabe, et al.
Japanese Journal of Pharmacology|June 1, 1997
Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogsM Inami, I Kawamura, Y Naoe, et al.
Folia Psychiatrica Et Neurologica Japonica|January 1, 1981
Psychomotor status induced by temporal lobe encephalitisM Murasaki, M Inami, K Okamoto, et al.
Anticancer Research|May 5, 1999
Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitorI Kawamura, N Yamamoto, F Sakai, et al.
Anticancer Research|January 11, 2000
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKII Kawamura, E Lacey, M Inami, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1999
Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in miceF Nishigaki, S Tsujimoto, M Inami, et al.
Anticancer Research|November 4, 2000
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activityS Tsujimoto, I Kawamura, M Inami, et al.
Japanese Journal of Cancer Research : Gann|August 14, 1998
Cytotoxic mechanisms of FK317, a new class of bioreductive agent with potent antitumor activityY Naoe, M Inami, I Kawamura, et al.
Japanese Journal of Cancer Research : Gann|March 19, 1999
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in miceY Naoe, I Kawamura, M Inami, et al.
Pageof 3